- Oral presentation
- Open Access
Guanylyl cyclase-A mediated endothelial actions of natriuretic peptides are critically involved in postischemic reperfusion
© Kuhn et al; licensee BioMed Central Ltd. 2007
- Published: 25 July 2007
- Natriuretic Peptide
- Therapeutic Angiogenesis
- Hindlimb Ischemia
- Intracellular cGMP
- Laser Doppler Perfusion Imager
Published studies have revealed protective actions of high levels of natriuretic peptides on vascular regeneration in response to ischemia. BNP overexpressed systemically in transgenic mice or gene transfer of CNP into ischemic muscles effectively accelerates angiogenesis . These studies suggest that pharmacological levels of exogenous NPs might be used as a strategy of therapeutic angiogenesis. However, they do not reveal whether endogenous NPs exert (patho-) physiological vasculoprotective actions. To investigate this question, we studied the impact of genetic ablation of guanylyl cyclase-A (GC-A), the receptor for ANP and BNP, on postocclusive hindlimb ischemia in mice.
The right femoral artery and vein were excised under anesthesia. A Laser Doppler Perfusion Imager (LDPI) was used to estimate relative blood flow during seven weeks following surgery. These functional in vivo studies were complemented with studies on cultured primary murine lung endothelial cells (MLEC).
Serial blood flow measurements by LDPI revealed that postocclusive hindlimb perfusion was severly impaired in mice with global GC-A deletion (GC-A-/-) as compared to respective WT mice. The calculated perfusion ratio of ischemic to nonischemic hindlimb was 0.15 ± 0.02 for WT vs. 0.09 ± 0.007 for GC-A-/- mice at day 3 (P = 0.02). After 35 days, restoration of perfusion in GC-A-/- mice was still drastically reduced demonstrating that endogenous NPs, via GC-A, exert important vasculoprotective actions. To dissect the specific vascular cell type mediating this effect, we took advantage of two genetic mouse lines with conditional, cell-restricted deletion of GC-A either in smooth muscle (SMC GC-A KO) or in endothelial cells (EC GC-A KO), both previously generated in our laboratory [2, 3]. In SMC GC-A KO mice the extent of restoration of perfusion at any time point was close to control littermates. In contrast, in EC GC-A KO mice postocclusive hindlimb perfusion was severely impaired during the whole observation period.
Incubation of cultured MLEC with ANP increased intracellular cGMP, activity of cGMP-dependent protein kinase I (PKG I) and phosphorylation of the extracellular signal regulated kinase ERK1/2. These responses were completely abolished in GC-A-deficient MLEC.
We conclude that endogenous ANP and/or BNP exert critical endothelium-mediated vasculoprotective effects after arterial occlusion. Our future studies will be directed to elucidate whether these effects are related to (PKG I, ERK-dependent?) endothelial regeneration and angiogenesis or to endothelium-dependent vasodilatation.
Supported by Deutsche Forschungsgemeinschaft (SFB 688).
- Yamahara K, Itoh H, Chun TH, Ogawa Y, Yamashita J, Sawada N, Fukunaga Y, Sone M, Yurugi-Kobayashi T, Miyashita K: Significance and therapeutic potential of the natriuretic peptides/cGMP/cGMP-dependent protein kinase pathway in vascular regeneration. Proc Natl Acad Sci. 2003, 100: 3404-3409. 10.1073/pnas.0538059100.PubMed CentralView ArticlePubMedGoogle Scholar
- Holtwick R, Gotthardt M, Skryabin B, Steinmetz M, Potthast R, Zetsche B, Hammer RE, Herz J, Kuhn M: Smooth muscle-selective deletion of guanylyl cyclase-A prevents the acute but not chronic effects of ANP on blood pressure. Proc Natl Acad Sci. 2002, 99: 7142-7147. 10.1073/pnas.102650499.PubMed CentralView ArticlePubMedGoogle Scholar
- Sabrane K, Kruse MN, Fabritz L, Zetsche B, Mitko D, Skryabin BV, Zwiener M, Baba HA, Yanagisawa Y, Kuhn M: Vascular endothelium is critically involved in the hypotensive and hypovolemic actions of atrial natriuretic peptide. J Clin Invest. 2005, 115: 1666-1674. 10.1172/JCI23360.PubMed CentralView ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd.